Development of a novel pro tool for use in clinical trials to measure symptoms in patients with non-cystic fibrosis bronchiectasis with and without non-tuberculous mycobacterial lung infection
Ended Cooperative Agreement Awarded Last action
- Award ID
- U01FD006687
- Recipient
-
Insmed Incorporated UEI GLE1HZQ47JW6
- Awarding agency
-
FDA Office of Acquisition and Grant Services
Food and Drug Administration, Department of Health and Human Services
- Obligated
- $1,690,567
Award facts
- Assistance listing
- 93.103 Food and Drug Administration Research
- Completion date
- Originally
- Funding agency
- Center for Drug Evaluation and Research Food and Drug Administration, Department of Health and Human Services
- Place of performance
- New Jersey, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | -$148,473 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Original award | $1,839,040 |
Quick answers
Who received award U01FD006687?
U01FD006687 was awarded to Insmed Incorporated by FDA Office of Acquisition and Grant Services (Food and Drug Administration) on September 1, 2019.
How much is award U01FD006687 worth?
$1,690,567 has been obligated on U01FD006687.
Which agency awarded U01FD006687?
FDA Office of Acquisition and Grant Services (Food and Drug Administration) awarded U01FD006687, with funding from Center for Drug Evaluation and Research (Food and Drug Administration).
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award